At the lumbar spine , 3 year mean BMD change for the 77 women receiving anastrozole/risedronate was 11 % ( 95 % CI 02 to 21 ) versus -26 % ( -40 to -13 ) for the 73 women receiving anastrozole/placebo ( p < 00001 ) .